{
"info": {
"nct_id": "NCT00343668",
"official_title": "A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy",
"inclusion_criteria": "* Pathologically proven unresectable adenocarcinoma of stomach\n* With uni-dimensionally measurable disease (at least longest diameter 2 cm on conventional CT scan, x-ray or physical examination, or 1cm on spiral CT scan)\n* Age 18 to 70 years old\n* Estimated life expectancy of more than 3 months\n* ECOG performance status of 2 or lower\n* Adequate bone marrow function(absolute neutrophil count [ANC] ≥1,500/µL, hemoglobin ≥9.0 g/dL,and platelets ≥100,000/µL)\n* Adequate kidney function (serum creatinine < 1.5 mg/dL)\n* Adequate liver function (serum total bilirubin < 2 times the upper normal limit (UNL); serum transaminases levels <3 times [<5 times for patients with liver metastasis] UNL)\n* No prior chemotherapy but prior adjuvant chemotherapy finished at least 6 months before enrollment was allowed. (but, prior adjuvant chemotherapy with capecitabine or S-1 or camptothecin analogues was excluded)\n* No prior radiation therapy for at least 4 weeks before enrollment in the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* Other tumor type than adenocarcinoma\n* Central nervous system (CNS) metastases or prior radiation for CNS metastases\n* Gastric outlet obstruction or intestinal obstruction\n* Evidence of gastrointestinal bleeding\n* The patient has bony lesions as the sole evaluable disease.\n* Past or concurrent history of neoplasm other than stomach cancer, except for curatively treated non-melanoma skin cancer or in situ carcinoma of the cervix uteri\n* Pregnant or lactating women, women of childbearing potential not employing adequate contraception\n* Other serious illness or medical conditions\n\n * Unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry\n * History of significant neurologic or psychiatric disorders including dementia or seizures\n * Active uncontrolled infection\n * Other serious underlying medical conditions which could impair the ability of the patient to participate in the study\n* Concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy\n* concomitant drug medication; The following drugs cause drug interaction with S-1.\n\n i. Warfarin, phenprocoumon: increase bleeding tendency ii. Increase blood concentration of phenytoin iii. sorivudine: inhibit DPD -> increase toxicity according to fluoropyrimidine iv. allopurinol : decrease activity of S-1",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Pathologically proven unresectable adenocarcinoma of stomach",
"criterions": [
{
"exact_snippets": [
"Pathologically proven"
],
"criterion": "adenocarcinoma",
"requirement_type": "confirmation method",
"expected_value": "pathological"
},
{
"exact_snippets": [
"unresectable"
],
"criterion": "adenocarcinoma",
"requirement_type": "resectability",
"expected_value": false
},
{
"exact_snippets": [
"adenocarcinoma of stomach"
],
"criterion": "adenocarcinoma",
"requirement_type": "location",
"expected_value": "stomach"
}
]
},
{
"line": "* With uni-dimensionally measurable disease (at least longest diameter 2 cm on conventional CT scan, x-ray or physical examination, or 1cm on spiral CT scan)",
"criterions": [
{
"exact_snippets": [
"uni-dimensionally measurable disease"
],
"criterion": "disease",
"requirement_type": "measurability",
"expected_value": true
},
{
"exact_snippets": [
"longest diameter 2 cm on conventional CT scan, x-ray or physical examination"
],
"criterion": "longest diameter",
"requirement_type": "minimum value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2
}
]
}
},
{
"exact_snippets": [
"1cm on spiral CT scan"
],
"criterion": "longest diameter",
"requirement_type": "minimum value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1
}
]
}
}
]
},
{
"line": "* Age 18 to 70 years old",
"criterions": [
{
"exact_snippets": [
"Age 18 to 70 years old"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18
},
{
"operator": "<=",
"value": 70
}
]
}
}
]
},
{
"line": "* Estimated life expectancy of more than 3 months",
"criterions": [
{
"exact_snippets": [
"Estimated life expectancy",
"more than 3 months"
],
"criterion": "life expectancy",
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3
}
}
]
},
{
"line": "* ECOG performance status of 2 or lower",
"criterions": [
{
"exact_snippets": [
"ECOG performance status of 2 or lower"
],
"criterion": "ECOG performance status",
"requirement_type": "severity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2
}
]
}
}
]
},
{
"line": "* Adequate bone marrow function(absolute neutrophil count [ANC] ≥1,500/µL, hemoglobin ≥9.0 g/dL,and platelets ≥100,000/µL)",
"criterions": [
{
"exact_snippets": [
"Adequate bone marrow function",
"absolute neutrophil count [ANC] ≥1,500/µL"
],
"criterion": "absolute neutrophil count",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1500
}
]
}
},
{
"exact_snippets": [
"Adequate bone marrow function",
"hemoglobin ≥9.0 g/dL"
],
"criterion": "hemoglobin",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 9.0
}
]
}
},
{
"exact_snippets": [
"Adequate bone marrow function",
"platelets ≥100,000/µL"
],
"criterion": "platelets",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 100000
}
]
}
}
]
},
{
"line": "* Adequate kidney function (serum creatinine < 1.5 mg/dL)",
"criterions": [
{
"exact_snippets": [
"Adequate kidney function",
"serum creatinine < 1.5 mg/dL"
],
"criterion": "kidney function",
"requirement_type": "adequacy",
"expected_value": true
},
{
"exact_snippets": [
"serum creatinine < 1.5 mg/dL"
],
"criterion": "serum creatinine",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1.5
}
}
]
},
{
"line": "* Adequate liver function (serum total bilirubin < 2 times the upper normal limit (UNL); serum transaminases levels <3 times [<5 times for patients with liver metastasis] UNL)",
"criterions": [
{
"exact_snippets": [
"Adequate liver function"
],
"criterion": "liver function",
"requirement_type": "adequacy",
"expected_value": true
},
{
"exact_snippets": [
"serum total bilirubin < 2 times the upper normal limit (UNL)"
],
"criterion": "serum total bilirubin",
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 2
}
]
}
},
{
"exact_snippets": [
"serum transaminases levels <3 times [<5 times for patients with liver metastasis] UNL"
],
"criterion": "serum transaminases levels",
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 3
},
{
"operator": "<",
"value": 5
}
]
}
}
]
},
{
"line": "* No prior chemotherapy but prior adjuvant chemotherapy finished at least 6 months before enrollment was allowed. (but, prior adjuvant chemotherapy with capecitabine or S-1 or camptothecin analogues was excluded)",
"criterions": [
{
"exact_snippets": [
"No prior chemotherapy"
],
"criterion": "prior chemotherapy",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"prior adjuvant chemotherapy finished at least 6 months before enrollment was allowed"
],
"criterion": "prior adjuvant chemotherapy",
"requirement_type": "completion time",
"expected_value": ">= 6 months before enrollment"
},
{
"exact_snippets": [
"prior adjuvant chemotherapy with capecitabine or S-1 or camptothecin analogues was excluded"
],
"criterion": "prior adjuvant chemotherapy",
"requirement_type": "medication type",
"expected_value": [
"capecitabine",
"S-1",
"camptothecin analogues"
]
}
]
},
{
"line": "* No prior radiation therapy for at least 4 weeks before enrollment in the study",
"criterions": [
{
"exact_snippets": [
"No prior radiation therapy"
],
"criterion": "radiation therapy",
"requirement_type": "prior treatment",
"expected_value": false
},
{
"exact_snippets": [
"at least 4 weeks before enrollment"
],
"criterion": "time since last radiation therapy",
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 4
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": [
"maximum age of 70 Years"
],
"criterion": "age",
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Other tumor type than adenocarcinoma",
"criterions": [
{
"exact_snippets": [
"Other tumor type than adenocarcinoma"
],
"criterion": "tumor type",
"requirement_type": "exclusion",
"expected_value": "adenocarcinoma"
}
]
},
{
"line": "* Central nervous system (CNS) metastases or prior radiation for CNS metastases",
"criterions": [
{
"exact_snippets": [
"Central nervous system (CNS) metastases"
],
"criterion": "CNS metastases",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"prior radiation for CNS metastases"
],
"criterion": "radiation for CNS metastases",
"requirement_type": "history",
"expected_value": true
}
]
},
{
"line": "* Gastric outlet obstruction or intestinal obstruction",
"criterions": [
{
"exact_snippets": [
"Gastric outlet obstruction"
],
"criterion": "gastric outlet obstruction",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"intestinal obstruction"
],
"criterion": "intestinal obstruction",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Evidence of gastrointestinal bleeding",
"criterions": [
{
"exact_snippets": [
"Evidence of gastrointestinal bleeding"
],
"criterion": "gastrointestinal bleeding",
"requirement_type": "evidence",
"expected_value": true
}
]
},
{
"line": "* The patient has bony lesions as the sole evaluable disease.",
"criterions": [
{
"exact_snippets": [
"bony lesions"
],
"criterion": "bony lesions",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"sole evaluable disease"
],
"criterion": "evaluable disease",
"requirement_type": "type",
"expected_value": "bony lesions"
}
]
},
{
"line": "* Past or concurrent history of neoplasm other than stomach cancer, except for curatively treated non-melanoma skin cancer or in situ carcinoma of the cervix uteri",
"criterions": [
{
"exact_snippets": [
"Past or concurrent history of neoplasm other than stomach cancer"
],
"criterion": "neoplasm",
"requirement_type": "history",
"expected_value": false
},
{
"exact_snippets": [
"curatively treated non-melanoma skin cancer"
],
"criterion": "non-melanoma skin cancer",
"requirement_type": "treatment status",
"expected_value": "curatively treated"
},
{
"exact_snippets": [
"in situ carcinoma of the cervix uteri"
],
"criterion": "carcinoma of the cervix uteri",
"requirement_type": "stage",
"expected_value": "in situ"
}
]
},
{
"line": "* Pregnant or lactating women, women of childbearing potential not employing adequate contraception",
"criterions": [
{
"exact_snippets": [
"Pregnant"
],
"criterion": "pregnancy",
"requirement_type": "status",
"expected_value": false
},
{
"exact_snippets": [
"lactating women"
],
"criterion": "lactation",
"requirement_type": "status",
"expected_value": false
},
{
"exact_snippets": [
"women of childbearing potential",
"not employing adequate contraception"
],
"criterion": "contraception",
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"line": "* Other serious illness or medical conditions",
"criterions": [
{
"exact_snippets": [
"serious illness"
],
"criterion": "illness",
"requirement_type": "severity",
"expected_value": "serious"
},
{
"exact_snippets": [
"medical conditions"
],
"criterion": "medical conditions",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Unstable cardiac disease despite treatment, myocardial infarction within 6 months prior to study entry",
"criterions": [
{
"exact_snippets": [
"Unstable cardiac disease"
],
"criterion": "cardiac disease",
"requirement_type": "stability",
"expected_value": false
},
{
"exact_snippets": [
"myocardial infarction within 6 months prior to study entry"
],
"criterion": "myocardial infarction",
"requirement_type": "time since occurrence",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 6
}
]
}
}
]
},
{
"line": "* History of significant neurologic or psychiatric disorders including dementia or seizures",
"criterions": [
{
"exact_snippets": [
"History of significant neurologic or psychiatric disorders"
],
"criterion": "neurologic disorders",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"History of significant neurologic or psychiatric disorders"
],
"criterion": "psychiatric disorders",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"including dementia"
],
"criterion": "dementia",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"including",
"seizures"
],
"criterion": "seizures",
"requirement_type": "history",
"expected_value": true
}
]
},
{
"line": "* Active uncontrolled infection",
"criterions": [
{
"exact_snippets": [
"Active uncontrolled infection"
],
"criterion": "infection",
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"line": "* Other serious underlying medical conditions which could impair the ability of the patient to participate in the study",
"criterions": [
{
"exact_snippets": [
"serious underlying medical conditions"
],
"criterion": "underlying medical conditions",
"requirement_type": "severity",
"expected_value": "serious"
},
{
"exact_snippets": [
"impair the ability of the patient to participate in the study"
],
"criterion": "ability to participate in the study",
"requirement_type": "impairment",
"expected_value": true
}
]
},
{
"line": "* concomitant drug medication; The following drugs cause drug interaction with S-1.",
"criterions": [
{
"exact_snippets": [
"concomitant drug medication"
],
"criterion": "concomitant drug medication",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"The following drugs cause drug interaction with S-1"
],
"criterion": "drug interaction with S-1",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "i. Warfarin, phenprocoumon: increase bleeding tendency ii. Increase blood concentration of phenytoin iii. sorivudine: inhibit DPD -> increase toxicity according to fluoropyrimidine iv. allopurinol : decrease activity of S-1",
"criterions": [
{
"exact_snippets": [
"Warfarin, phenprocoumon: increase bleeding tendency"
],
"criterion": "Warfarin, phenprocoumon",
"requirement_type": "effect",
"expected_value": "increase bleeding tendency"
},
{
"exact_snippets": [
"Increase blood concentration of phenytoin"
],
"criterion": "phenytoin",
"requirement_type": "blood concentration",
"expected_value": "increase"
},
{
"exact_snippets": [
"sorivudine: inhibit DPD -> increase toxicity according to fluoropyrimidine"
],
"criterion": "sorivudine",
"requirement_type": "interaction",
"expected_value": "inhibit DPD -> increase toxicity according to fluoropyrimidine"
},
{
"exact_snippets": [
"allopurinol : decrease activity of S-1"
],
"criterion": "allopurinol",
"requirement_type": "effect",
"expected_value": "decrease activity of S-1"
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Concomitant administration of any other experimental drug under investigation, or concomitant chemotherapy, hormonal therapy, or immunotherapy",
"criterions": [
{
"exact_snippets": [
"Concomitant administration of any other experimental drug under investigation"
],
"criterion": "experimental drug",
"requirement_type": "concomitant administration",
"expected_value": false
},
{
"exact_snippets": [
"concomitant chemotherapy"
],
"criterion": "chemotherapy",
"requirement_type": "concomitant administration",
"expected_value": false
},
{
"exact_snippets": [
"concomitant hormonal therapy"
],
"criterion": "hormonal therapy",
"requirement_type": "concomitant administration",
"expected_value": false
},
{
"exact_snippets": [
"concomitant immunotherapy"
],
"criterion": "immunotherapy",
"requirement_type": "concomitant administration",
"expected_value": false
}
]
}
],
"failed_miscellaneous": []
}